We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Venture Life Group Plc | LSE:VLG | London | Ordinary Share | GB00BFPM8908 | ORD 0.3P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 39.00 | 38.50 | 39.50 | 39.00 | 39.00 | 39.00 | 15,567 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Misc Retail Stores, Nec | 43.98M | 520k | 0.0041 | 95.12 | 49.07M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/4/2018 13:20 | I see comments saying email marketing is going to decline by commentators on DOTD. 18 current vacancies (cf 10) "Cross-channel marketing or multi-channel marketing or omni-channel marketing or whatever term you prefer is all about engaging with your customer or prospect across every digital channel and any device. From the inbox to social networks to the web, and across laptops, tablets, and smartphones, today’s consumer moves seamlessly and fully expects you to be there with them, providing a true integrated experience." This is the name of DOTD's game (horrid marketing speak). email marketing comments are just so yesterday. Comfortable with DOTD. Thanks, red. It's hard to talk to pals about their investments, whilst leaving the decisions to them. I found myself mouthing the usual platitudes about investing to my daughter and then realised that my own success has flouted all those rules. Regression to the mean! What a fopdoodle! apad | apad | |
28/4/2018 23:58 | To become successful trading binary options requires a lot of hard work, practice, dedication and determination to become an independent trader. Find out how my team of professionals make thousands weekly. Email: lifeofpiotr@gmail.co | lifeofpiotr | |
28/4/2018 21:06 | Google does like its moon shot spending thats for sure. I like the liquid assets available. Lowers true PE by quite a chunk. Ultimate company would be a merger of amazon (JB) and alphabet. Quite possibly would be too powwrful. | thelongandtheshortandthetall | |
28/4/2018 18:56 | Flag: NTQ is frisky and its results are mid June. apad | apad | |
28/4/2018 18:43 | Thanks APAD - as usual, a unique and interesting viewpoint | hydrus | |
28/4/2018 18:38 | No, Hydrus, I don't pay for TW articles. I approve of his campaigning and he provides data to justify his point of view. I assume his style is advertising and it doesn't bother me one way or another. "Walk between the raindrops, smooth as a pearl" He did organise an Investor Show where I saw the CEO of FFX make a dragon's den presentation. However, the tips and comments on the site are painfully trivial. On recommendations, I rate Paul Scott and tried to make a donation once, but it wanted too much personal data. Yup. Very interesting insight, Iomax. Ta. bamboo, FARN is so little traded I'm not sure what one can deduce from the chart. "If the drug is near 100% certain, isn't this mostly in the price already?" The efficient market theory - Yeah Right! apad😎 | apad | |
28/4/2018 17:28 | Thanks Iomax useful to see. Got in AMZN at circa 550p. Fair bit behind Mod. Still annoyed I didn't invest back in the early 2000's when I was using their services. Fun fact - it's been a 100 bagger twice. Once in the tech boom and then again post 2000. | hydrus | |
28/4/2018 17:24 | I am happy with my holding in Amazon,and tempted to add. The FT’s Lex column highlights the growth in their advertising revenues. It surmises that most of the c. $2bn of the “other” revenue line in their recently quarterly results was advertising, that this had doubled year on year, and was likely to reach c. $10bn for the full year. Even then that will be only half AWS’s size. Great to have two decent, fast growing, revenue stream’s with fatter margins than core ecommerce. | lomax99 | |
28/4/2018 17:11 | On Woodford* ........Afternoon drinking is bad for brain cells | hydrus | |
28/4/2018 17:07 | APAD do you pay for winniforth's articles or just get a the free ones?He may be right on Winniforth but I find his aggressive style unpalatable and wouldn't want to give him a penny. | hydrus | |
28/4/2018 16:35 | Re farn, thanks for the reply and mod for the info. If the drug is near 100% certain, isn't this mostly in the price already? The chart looks rangebound. There are some potential turns that could indicate activity in the chart. 11-15/5/2018, and 4/6/2018. Watch prior trend for direction, if any. | bamboo2 | |
28/4/2018 16:30 | I've never understood the way google spends so-called R&D money, Hydrus. Just looks like a playground. Winnifroth's revelations about Woodford are shocking. FARN FY 8 May. apad | apad | |
28/4/2018 16:15 | I've been looking at google and amazon and the difference in the rating between the two, to see if google is genuinely cheap. My conclusion is that google is chucking R&D money left, right and centre with no strategy and certainly no clear commercial payback. Amazon is focussed and efficient and is spending money sensibly. The difference between the two is Jeff Bezos. A brilliant CEO who is an owner is a critical part of the jigsaw puzzle.I'm up 18.5% this year following >100% last year. Poor old woody Woodford needs to look at this thread a bit more. | hydrus | |
28/4/2018 12:43 | Those were the days, mod! 266p my first purchase These purchases testify to my FARN addiction. apad😊 FARN 9-Jan-2017 FARN 17-Jan-2017 FARN 24-Apr-2017 FARN 9-May-2017 FARN 11-Jul-2017 FARN 26-Oct-2017 FARN 2-Nov-2017 FARN 2-Nov-2017 FARN 13-Nov-2017 FARN 14-Nov-2017 FARN 14-Nov-2017 FARN 18-Dec-2017 FARN 19-Dec-2017 FARN 21-Dec-2017 FARN 29-Dec-2017 FARN 24-Apr-2018 FARN 24-Apr-2018 FARN 24-Apr-2018 FARN 26-Apr-2018 | apad | |
28/4/2018 10:51 | Apad, it's worthwhile noting that most of us including you dipped our toes in at around 270, my average entry is below 350, early stage pharma is either a multibag or almost nothing, but can be accommodated as a part of PF risk management, if you allocate a small amount to it, but it depends highly on individuals personal circumstances. I have 2 early stage pharma, FARN and DNL, both very high risk imo. | modform | |
28/4/2018 10:11 | "Thanks apad, is it 100% certain?" & Big7. The Phase II trial results were overwhelming and it was a close run thing as to whether approval would be granted straightaway. In my view the Phase III's main task is to differentiate types of patients. It is authorised for use in extreme (I forget the official term) cases. Company raised money at 805p to start manufacturing facilities. I think decimate is a mild term for what would happen if the trial failed, Big7. apad😊 | apad | |
28/4/2018 10:01 | APAD re 18598 I think I am a contrarian investor. Unusual I have found is profitable When a shr/sector is unloved it can be an absolute bargain. When it's a dead cert, or everyone seems to be buying - that's the time to be thinking of selling in my experience hence my previous question My timing isn't the best but I prefer to think of it as ahead of the crowd | big7ime | |
28/4/2018 09:38 | APAD I don't follow FARN and know nothing about it but how can you be so certain? And isn't that rather dangerous if (as is often the case with pharm cos) they do not get the result people are expecting!? Wouldn't it decimate the sp | big7ime | |
28/4/2018 09:20 | cbootle re BAB, it was attacked by shorters but I think those positions are unwinding. Liberum has a £11 target and RBC £10 | robow | |
28/4/2018 09:17 | I average a 90% - 98% success win rate using IQoption and 24option. You can feel free to join my team of professionals. DM- lifeofpiotr@gmail | lifeofpiotr |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions